RINGLOC + HYBRID ACETABULAR SYSTEM— 510(k) K093235
Substantially EquivalentBiomet, Inc.
FDA 510(k) clearance K093235 for RINGLOC + HYBRID ACETABULAR SYSTEM, Substantially Equivalent on 2010-04-30. Applicant: Biomet, Inc.. Device class: 3.
Clearance details
- Applicant
- Biomet, Inc.
- Product code
- Code KWA
- Device class
- Class 3
- Regulation
- 21 CFR 888.3330
- Advisory panel
- Orthopedic
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Warsaw, IN, US
Recent devices under product code KWA
view allMore clearances from Biomet, Inc.
view allAdverse events under product code KWA
product code KWA- Death
- 38
- Injury
- 10,439
- Malfunction
- 1,862
- Total
- 12,339
Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →
Recalls naming K093235
K-number listed on FDA's recall record- Z-0312-2018 — PPS RingLoc+ Acetabular Shell, RNGLC+ LTD HOLE SHELL SZ62 The Porous Plasma Spray (PPS) Ringloc¿+ Acetabular System is intended to replace the natural acetabulurn damaged by disease, trauma or revision of previous arthroplasty. The Porous Plasma Spray (PPS) Ringloc¿+ Acetabular System is intended for uncemented use only.
- Z-2483-2015 — Vision RingLoc Shell 50 mm Size 23. Hip joint replacement prosthesis.
- Z-1123-2015 — Ringloc+ Acetabular Shell Finned 52 mm, PN 16-104152, hip prosthesis component.
Matched by K-number from FDA's Recall Enterprise System record (openFDA device/recallk_numbers) — these recalls explicitly list K093235.
Data sourced from openFDA. This site is unofficial and independent of the FDA.